• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Decade Study Tracks Incarceration and Injecting Risk Among Melbourne Drug Users

by
November 19, 2026
in Health
Reading Time: 5 mins read
0
Decade Study Tracks Incarceration and Injecting Risk Among Melbourne Drug Users

Decade Study Tracks Incarceration and Injecting Risk Among Melbourne Drug Users

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A ten-year longitudinal study following a community-based cohort of people who inject drugs in Melbourne, Australia, found that two-thirds reported a lifetime history of incarceration, with recent imprisonment rates remaining persistently above twenty percent across a decade of follow-up. Published in Health and Justice, the investigation tracked participants enrolled in the Melbourne Injecting Drug Use Cohort Study, known as SuperMIX, between 2008 and 2021. The research team, led by Jocelyn Chan and colleagues, examined self-reported criminal justice interactions and custodial risk behaviours among community-recruited individuals. Their analysis revealed that custodial experiences were characterized by frequent cycling through detention facilities, profound socioeconomic marginalization, and high levels of high-risk injecting practices within correctional environments where formal sterile equipment distribution programs remain absent.

To capture patterns outside institutional settings, researchers recruited participants from street-based drug markets, needle and syringe programs, and primary healthcare clinics across Melbourne using respondent-driven and convenience sampling. Eligible individuals were Victoria residents aged eighteen or older who reported injecting an illicit drug at least monthly during the previous six months, held a valid Medicare number for administrative linkage, and provided informed consent. Across annual face-to-face and pandemic-era telephone interviews, fieldworkers gathered detailed information on participants’ socio-demographic backgrounds, drug use patterns, physical and psychological health, healthcare utilization, and criminal justice histories. Out of 1,328 enrolled participants, complete incarceration data were available for 1,307 individuals, spanning interviews conducted between April 2008 and March 2021 with a median interval of 372 days between consecutive assessments.

The study recorded outcome variables documenting lifetime contact with police cells, remand centres, prisons, and youth detention facilities, alongside self-reported occurrences since the preceding interview. Baseline evaluations demonstrated that 66.7 percent of the cohort, comprising 872 of 1,307 individuals, had experienced at least one lifetime incarceration episode. Furthermore, annual follow-up interviews indicated that between 21 percent and 35 percent of respondents experienced an incarceration episode in any given year. Statistical evaluation using chi-squared tests for trend demonstrated no significant longitudinal decline in annual incarceration prevalence across the follow-up window for either men or women, establishing that criminal justice involvement remained a constant feature of participants’ lives rather than diminishing over time.

A comparison of baseline characteristics between participants with and without custodial histories highlighted stark differences in social and economic stability. Individuals who had experienced incarceration were significantly more likely to be male, representing 74.9 percent of the incarcerated group compared to 53.6 percent among those never incarcerated. Aboriginal and Torres Strait Islander individuals made up 14.7 percent of the incarcerated group compared to 6.9 percent of the non-incarcerated group. Participants with incarceration histories also reported substantially higher rates of socioeconomic disadvantage: 40.2 percent had completed nine or fewer years of formal education compared to 20.7 percent of those without custodial records, 91.4 percent were unemployed compared to 83.4 percent, and 35.5 percent lived in unstable accommodation compared to 27.0 percent. While primary substance choices and risky alcohol use scores were comparable, individuals with prior incarceration initiated injecting drug use at an earlier median age of 17 years compared to 18 years.

Detailed episodic accounts provided by 910 participants covering 2,260 discrete custodial episodes revealed distinct patterns across demographic lines. Women reported a slightly younger median age at first incarceration than men, at 26 years versus 28 years, and were more likely to report only a single incarceration episode, at 27.7 percent versus 18.1 percent. In contrast, 31.3 percent of men reported experiencing four or more lifetime episodes compared to 16.5 percent of women. Men also experienced longer durations of confinement, recording a median stay of 4.1 months compared to 1.4 months for women. Additionally, 26.4 percent of custodial episodes among women were confined entirely to police cells without progression to correctional centres, compared to 17.5 percent among men.

Disparities were also pronounced when evaluating custodial experiences by Indigenous status. Aboriginal and Torres Strait Islander participants reported a longer median duration of incarceration than non-Indigenous participants, at 4.1 months versus 3.0 months, despite recording an older median age at first reported confinement of 29 years compared to 27 years. A higher proportion of incarceration episodes among Aboriginal and Torres Strait Islander respondents occurred in prisons, accounting for 72.2 percent of their reported episodes compared to 62.9 percent among non-Indigenous peers. Over the pooled follow-up period from 2009 to 2022, the proportion reporting an episode since their prior interview was significantly higher among Aboriginal and Torres Strait Islander participants at 42.1 percent compared to 25.9 percent for non-Indigenous participants, with annual proportions rising from 33 percent in 2010 to 55 percent in 2022, though this upward trajectory did not reach statistical significance.

Custodial drug consumption and high-risk practices were documented across a notable proportion of detention periods. Nearly one-fifth of all detailed incarceration episodes, representing 19.4 percent, involved illicit injecting drug use while in custody. Injecting was most frequently reported during stays in adult prisons at 26.5 percent and juvenile justice facilities at 21.7 percent, while occurring less frequently in remand facilities at 12.1 percent and police cells at under one percent. The probability of injecting rose sharply with prolonged confinement, reaching 50.8 percent among individuals detained for thirty-six months or longer. Across all custodial injecting events, 75.2 percent involved syringe sharing, reflecting widespread equipment reuse across prison and remand environments regardless of sentence length.

Among participants who injected while incarcerated, heroin was the most commonly reported substance, identified in 60.0 percent of episodes, followed by buprenorphine-naloxone at 24.2 percent, buprenorphine alone at 24.2 percent, and methamphetamine at 20.2 percent, while methadone injection was documented in fewer than one percent of episodes. Historical comparisons indicated a temporal shift wherein heroin use declined over time alongside increases in buprenorphine-naloxone. Men were significantly more likely than women to report custodial injecting at 21.0 percent versus 13.6 percent, whereas injecting rates were comparable between Aboriginal and Torres Strait Islander participants at 20.7 percent and non-Indigenous participants at 19.2 percent. Syringe sharing remained consistently high across all demographic subdivisions.

Temporal analyses revealed shifting patterns in incarceration characteristics over the study decades. The median duration of custodial episodes decreased from six months for episodes occurring prior to 2000 to three months for those occurring after 2015. Concurrently, the proportion of episodes localized entirely within police watch houses rose from 15 percent before 2000 to 21 percent after 2015. The authors placed these observations within Australia’s broader policy environment, observing that while the National Drug Strategy 2017–2026 articulates balanced harm minimization principles, approximately 65 percent of the 2021/2022 national drug budget, totaling 3.5 billion dollars, was allocated to law enforcement measures. The researchers noted that no formal needle and syringe programs operate within Australian correctional facilities, despite international evidence supporting prison-based harm reduction and opioid agonist treatment expansion.

The authors identified methodological constraints, noting that custodial histories relied on retrospective self-report for up to four recent episodes across twelve-month recall windows, which may introduce recall inaccuracies or underestimate brief stays in police lockups and youth facilities. Cohort attrition was substantial, with 37.2 percent of enrolled individuals failing to complete a follow-up interview within two years of baseline. Because loss to follow-up was significantly higher among participants with incarceration histories, men, individuals with unstable housing, those using amphetamines as their primary drug, and those not receiving opioid agonist treatment, the researchers emphasized that the true community burden of incarceration and associated risks may be understated, while noting that findings from this urban Victorian cohort may not directly extrapolate to rural jurisdictions or differing international carceral systems.

Subject of Research: Longitudinal analysis of incarceration prevalence and custodial injecting risk among community-recruited people who inject drugs

Article Title: Ten-year longitudinal study of incarceration among a community-based cohort of people who inject drugs

Article References: Chan, J., Curtis, M., Clark, N., Hickman, M., Higgs, P., Jones, J., Livingston, M., Maher, L., Quinn, B., Stewart, A. C., Stone, J., Trauer, J., Stoové, M., & Dietze, P. (2026). Ten-year longitudinal study of incarceration among a community-based cohort of people who inject drugs. Health & Justice, 14(1), Article 51. https://doi.org/10.1186/s40352-026-00440-1

Image Credits: AI Generated

DOI: 10.1186/s40352-026-00440-1

Keywords: Incarceration, People Who Inject Drugs, SuperMIX Cohort, Harm Reduction, Melbourne, Longitudinal Study, Syringe Sharing, Prison Health, Remand, Aboriginal Health Disparities, Substance Use, Opioid Agonist Treatment, Heroin, Methamphetamine, Recidivism, Public Health, Epidemiology, Health Equity

News Source: Phoebe Ingram. (November 19, 2026). Decade Study Tracks Incarceration and Injecting Risk Among Melbourne Drug Users. Scienmag.

Tags: Aboriginal Health DisparitiesEpidemiologyharm reductionhealth equityheroinincarcerationlongitudinal studyMelbournemethamphetamineopioid agonist treatmentpeople who inject drugsprison healthPublic HealthrecidivismRemandsubstance useSuperMIX CohortSyringe Sharing
Share12Tweet7Share2ShareShareShare1

Related Posts

Literary Gerontology Study Analyzes Relational Identity and Dementia in Alice Munro's Fiction

Literary Gerontology Study Analyzes Relational Identity and Dementia in Alice Munro’s Fiction

November 19, 2026
Surgeons in Syria Safely Manage Two Giant Concomitant Hepatic Hydatid Cysts

Surgeons in Syria Safely Manage Two Giant Concomitant Hepatic Hydatid Cysts

November 19, 2026

Clinical Outcome Measures Evaluated for Patient Relevance in Amyotrophic Lateral Sclerosis

November 19, 2026

Adolescent Metabolic Burden Linked to Modestly Faster Annual Myopic Axial Elongation

November 19, 2026

POPULAR NEWS

  • Survey Shows Public Awareness Remains Low as U.S. Mpox Cases Persist

    Survey Shows Public Awareness Remains Low as U.S. Mpox Cases Persist

    29 shares
    Share 12 Tweet 7
  • Single Meningococcal Conjugate Dose Demonstrates Strong Immunity Across Age Groups in Vietnam

    29 shares
    Share 12 Tweet 7
  • German Preventive Health Economic Evaluations Often Rely on Foreign Data Sources

    29 shares
    Share 12 Tweet 7
  • Virtual Community of Practice Strengthens Ukrainian Trauma Care Training During Armed Conflict

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Literary Gerontology Study Analyzes Relational Identity and Dementia in Alice Munro’s Fiction

Surgeons in Syria Safely Manage Two Giant Concomitant Hepatic Hydatid Cysts

Clinical Outcome Measures Evaluated for Patient Relevance in Amyotrophic Lateral Sclerosis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.